Covered recipient · General Payments record
LIZA SCHAFFNER
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychiatry
General Payments · PY2023–2024
$578.35
- Reported across 32 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $408.39 | 24 |
| Education | $27.27 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $226.61 | 15 |
| Janssen Pharmaceuticals, Inc | $110.15 | 5 |
| E.R. Squibb & Sons, L.L.C. | $51.04 | 2 |
| Neurocrine BioSciences, Inc. | $17.28 | 1 |
| Alkermes, Inc. | $15.71 | 1 |
| Noven Therapeutics, LLC | $14.87 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.27 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030570 | CMS |
| ABBVIE INC. | $12.58 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030572 | CMS |
| ABBVIE INC. | $19.04 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030574 | CMS |
| ABBVIE INC. | $17.18 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030576 | CMS |
| ABBVIE INC. | $26.56 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030578 | CMS |
| ABBVIE INC. | $18.53 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030580 | CMS |
| ABBVIE INC. | $17.91 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030582 | CMS |
| ABBVIE INC. | $4.84 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030584 | CMS |
| ABBVIE INC. | $13.89 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030586 | CMS |
| ABBVIE INC. | $15.14 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030588 | CMS |
| ABBVIE INC. | $24.85 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030590 | CMS |
| ABBVIE INC. | $4.55 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030592 | CMS |
| ABBVIE INC. | $9.65 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030594 | CMS |
| ABBVIE INC. | $11.81 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030596 | CMS |
| ABBVIE INC. | $11.81 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106030598 | CMS |
| Alkermes, Inc. | $15.71 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120592789 | CMS |
| E.R. Squibb & Sons, L.L.C. | $27.27 | 12/03/2024 | Education | Undisputed | 01/23/2026 | 1101241248 | CMS |
| E.R. Squibb & Sons, L.L.C. | $23.77 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101241252 | CMS |
| Janssen Pharmaceuticals, Inc | $13.94 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078083798 | CMS |
| Janssen Pharmaceuticals, Inc | $21.37 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078083716 | CMS |
| Janssen Pharmaceuticals, Inc | $32.10 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078083184 | CMS |
| Janssen Pharmaceuticals, Inc | $21.37 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078083884 | CMS |
| Janssen Pharmaceuticals, Inc | $21.37 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078083412 | CMS |
| Neurocrine Biosciences, Inc. | $17.28 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150867954 | CMS |
| Noven Therapeutics, LLC | $14.87 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084823043 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.